SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is trending as investors react to positive regulatory updates, including FDA clearance for late-stage PTSD trials, which signals strong momentum ahead of imminent Phase 3 readouts. The community is actively debating the company's first-mover advantage versus long-term competitive threats, with sentiment bolstered by potential policy tailwinds and bipartisan support for psychedelic-assisted therapies.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

Rage Guy is trending as the community doubles down on the revival of internet culture through the restored Ragemaker tool, positioning it as an essential OG meme play. Supporters are actively coordinating daily across multiple platforms to build conviction, emphasizing that the project's historical roots and grassroots efforts distinguish it from newer, less established tokens.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is drawing intense community interest due to the potential for regulatory tailwinds and positive sentiment surrounding the psychedelic-assisted therapy sector. Discussions are currently centered on anticipation for upcoming Phase 3 trial data, speculative interest in potential M&A activity, and active debates among traders regarding the company's long-term commercial strategy versus historical governance concerns.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is seeing massive volatility and intense community speculation, fueled by a high-profile series of global events and allegations of a pump-and-dump scheme involving concentrated insider holdings. While some investors are betting on the token's utility in real-world event ticketing and short-squeeze potential, others are warning of a significant liquidity trap, leading to heated debates between bullish supporters anticipating further growth and skeptical traders calling for regulatory scrutiny.

Daddy Darth Sidious

SIDIOUS is gaining traction within a niche community of nano-cap traders who are actively debating its potential during a rotation from other meme assets. Participants are heavily focused on social media sentiment, community-driven volume pushes, and the competitive rivalry between related Star Wars-themed tokens.

Highstreet

Highstreet ($HIGH) is drawing significant community attention as traders debate whether its low circulating supply and recent price volatility signal an imminent short squeeze or a potential bear trap. Many participants are actively monitoring whale accumulation patterns and technical indicators, hoping for a rebound toward previous higher valuations.

PolySwarm

Polyswarm (NCT) is seeing intense community speculation as investors monitor low float dynamics and potential catalysts, with many hoping that increasing cybersecurity threats will drive adoption and volume. Traders are actively debating the timing of a breakout, with many focusing on technical accumulation patterns while remaining patient for a shift in broader market liquidity.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is trending as investors react to the company's recent rebranding and Nasdaq listing under the new ticker HELP, while anticipation builds around upcoming clinical data readouts for its major depressive disorder and generalized anxiety disorder programs. The community is actively debating the significance of these pipeline catalysts against the company's historical performance, with discussions heavily focused on institutional positioning, management transitions, and the long-term potential of the psychedelic therapeutics sector.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is gaining momentum as a critical infrastructure provider in the DeFi space, fueled by its recent launch of a data marketplace backed by major financial institutions and its role in supplying macroeconomic data to blockchain ecosystems. Community sentiment remains bullish, with investors actively discussing the project's institutional adoption, unique revenue-sharing model through token buybacks, and its positioning as a key player in the Real World Asset (RWA) narrative.

PRIME is the native token of the Echelon Prime Foundation, a Web3 ecosystem advancing the next generation of gaming. Echelon creates and distributes tools to encourage innovation in, and promote the growth of, novel gaming models and economies. The first game to adopt and utilize PRIME is Parallel, a sci-fi trading card game.

Echelon Prime

Echelon Prime is capturing significant attention as investors speculate on a broader reversal in the gaming and AI-linked crypto sectors. The community is actively discussing accumulation strategies during periods of high volatility, with many traders framing the token as an undervalued long-term play within the expanding Web3 gaming ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SKYX  My thinking:  COO Steve Schmidt coming out in Nov on significant hotel win soon will lead to a total repricing of SKYX. I believe he is the one that brought Shaner Group to SKYX. If so, the likelihood he was talking $MAR on the call is very high and the likelihood he&#39;s the most credible is backed by being an ex CEO of Nielsen ratings. Shaner group also has $HLT and $IHG properties. Remember, Shaner put a group together and invested in SKYX so its natural he&#39;s made introductions to corporates.  I  believe all are in talks with SKXY and NVDA will want  to play into this ecosystem throughout the world. I presume major discussions between SKYX and NVDA will come in 2026. $10-20M on low end maybe even a higher  investment would come if talks go in the right direction and 10-20 per share will come into focus.  BIG IF. 
 
Needs OVER 2.42 on close and good news to follow. 
 
200 weekly moving avg 2.31  
triple top 2.42 
50 day 2.06  
 
market accumulation 2.00-2.25 seems almost done, 2.25-2.42 up next?

Rbby

Dr. Lipschitz

HemorrhoidHarry

Sammolio

Microdreams

StockTwits Web

SKYX Platforms Corp

Marriott International Inc

Hilton Worldwide Holdings Inc

Intercontinental Hotels Group plc

  My thinking:  COO Steve Schmidt coming out in Nov on significant hotel win soon will lead to a total repricing of SKYX. I believe he is the one that brought Shaner Group to SKYX. If so, the likelihood he was talking 

 on the call is very high and the likelihood he's the most credible is backed by being an ex CEO of Nielsen ratings. Shaner group also has 

 properties. Remember, Shaner put a group together and invested in SKYX so its natural he's made introductions to corporates.  I  believe all are in talks with SKXY and NVDA will want  to play into this ecosystem throughout the world. I presume major discussions between SKYX and NVDA will come in 2026. $10-20M on low end maybe even a higher  investment would come if talks go in the right direction and 10-20 per share will come into focus.  BIG IF. 
 
Needs OVER 2.42 on close and good news to follow. 
 
200 weekly moving avg 2.31  
triple top 2.42 
50 day 2.06  
 
market accumulation 2.00-2.25 seems almost done, 2.25-2.42 up next?